| 19.21 0.01 (0.05%) | 12-08 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 22.94 | 1-year : | 26.8 |
| Resists | First : | 19.64 | Second : | 22.94 |
| Pivot price | 18.1 |
|||
| Supports | First : | 17.07 | Second : | 15.47 |
| MAs | MA(5) : | 18.98 |
MA(20) : | 17.73 |
| MA(100) : | 20.45  |
MA(250) : | 23.66 |
|
| MACD | MACD : | 0.4 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 82.3 |
D(3) : | 80.5 |
| RSI | RSI(14): 61.8 |
|||
| 52-week | High : | 34.36 | Low : | 15.02 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ TDOC ] has closed below upper band by 16.6%. Bollinger Bands are 17.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 19.65 - 19.73 | 19.73 - 19.8 |
| Low: | 18.58 - 18.67 | 18.67 - 18.76 |
| Close: | 19.07 - 19.2 | 19.2 - 19.34 |
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Fri, 08 Dec 2023
Ergoteles LLC Purchases New Position in Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Fri, 08 Dec 2023
Does Teladoc Health Inc (TDOC) Have What it Takes to be in Your Portfolio Friday? - InvestorsObserver
Thu, 07 Dec 2023
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - Yahoo Finance
Thu, 07 Dec 2023
Should You Hold Teladoc Health Inc (TDOC) Stock Thursday Morning? - InvestorsObserver
Wed, 06 Dec 2023
Is Teladoc Health Inc (TDOC) Stock Worth a Buy Wednesday? - InvestorsObserver
Mon, 04 Dec 2023
Analyst Rating: Will Teladoc Health Inc (TDOC) Stock Lead the Market? - InvestorsObserver
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Health Information Services
|
|
| Shares Out | 166 (M) |
| Shares Float | 164 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 82.5 (%) |
| Shares Short | 18,850 (K) |
| Shares Short P.Month | 24,220 (K) |
| EPS | -24.69 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.85 |
| Profit Margin | -155.2 % |
| Operating Margin | -8.9 % |
| Return on Assets (ttm) | -2.2 % |
| Return on Equity (ttm) | -95.9 % |
| Qtrly Rev. Growth | 8 % |
| Gross Profit (p.s.) | 10.02 |
| Sales Per Share | 15.58 |
| EBITDA (p.s.) | 0.13 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 285 (M) |
| Levered Free Cash Flow | 257 (M) |
| PE Ratio | -0.78 |
| PEG Ratio | 0.1 |
| Price to Book value | 1.38 |
| Price to Sales | 1.23 |
| Price to Cash Flow | 11.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|